首页> 外文期刊>Pharmaceutical patent analyst >P2X3 and P2X2/3 receptor antagonists
【24h】

P2X3 and P2X2/3 receptor antagonists

机译:P2X3和P2X2 / 3受体拮抗剂

获取原文
获取原文并翻译 | 示例
           

摘要

This review provides a concise summary of the molecular properties of the ligand-gated P2X receptors, in particular those containing the X3 subunit, as well as an overview comprising the most important patent applications on P2X3 and P2X2/3 receptor antagonists published since 2001. This review is mainly focused on small molecules with P2X3 and/or P2X2/3 antagonist properties. The most important classes of the patented compounds and conditions frequently claimed as their therapeutic targets are also discussed. Moreover, biological activity data from the cited patents and general prediction of druglikeness of the claimed compounds are also provided.
机译:这篇综述简要概述了配体门控的P2X受体的分子特性,尤其是那些包含X3亚基的受体,以及概述了自2001年以来发布的有关P2X3和P2X2 / 3受体拮抗剂的最重要的专利申请。综述主要集中在具有P2X3和/或P2X2 / 3拮抗剂特性的小分子上。还讨论了经常被要求作为其治疗目标的专利化合物和病症的最重要类别。此外,还提供了来自所引用专利的生物活性数据以及所要求保护的化合物的药物相似性的一般预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号